Oyama Hiroyuki, Kiguchi Yuki, Morita Izumi, Miyashita Takayuki, Ichimura Akiyoshi, Miyaoka Hiroko, Izumi Aki, Terasawa Sayaka, Osumi Natsumi, Tanaka Hiroki, Niwa Toshifumi, Kobayashi Norihiro
Kobe Pharmaceutical University, 4-19-1, Motoyama-Kitamachi, Higashinada-ku, Kobe, 658-8558, Japan.
Department of Medical Technology, School of Health Sciences, Tohoku University, 2-1, Seiryo-machi, Aoba-ku, Sendai, 980-8575, Japan.
Anal Chim Acta. 2021 May 29;1161:238180. doi: 10.1016/j.aca.2020.12.055. Epub 2021 Jan 6.
Enzyme-linked immunosorbent assays (ELISAs) are essential for monitoring various biomarkers. Competitive and noncompetitive (sandwich) assay formats are used to determine hapten and macromolecule levels, respectively. Both formats require more sensitive detection of reporter enzymes for greater assay sensitivities. We previously reported the utility of wild-type Gaussia luciferase (wtGLuc) as a fusion partner with antibody single-chain Fv fragments (scFvs) for developing sensitive luminescent ELISAs. Here, we evaluated utility of NanoLuc luciferase (NLuc), a recently developed luciferase, as fusion partner with scFvs from the view of comparison with wtGLuc and a mutant of alkaline phosphatase (ALP'). Thyroxine (T) and T-labeled albumin were chosen as model haptenic and macromolecular antigens, respectively. An in-house-prepared anti-T scFv was fused with NLuc, wtGLuc, or ALP'. The scFv-NLuc fusion protein showed 47-fold and 29-fold lower limit of detection [LOD; 59 zmol (per assay)] than the wtGLuc- and ALP'-fusions, respectively. In a competitive T ELISA, the NLuc-fusion showed 9.3- and 6.3-fold lower LOD, (0.67 pg) than the wtGLuc- and ALP'-fusions, respectively, with a higher specificity in clinical applications. A typical colorimetric ELISA using a peroxidase-labeled second antibody showed 70-fold higher LOD than NLuc-based ELISA. Another advantage of the NLuc-fusion was shown in the sandwich assays; the LOD of T-labeled albumin (5.0 fmol) was >6-fold lower than that of the other luminescent ELISAs. In an additional sandwich assay developed to count bacteriophage particles, NLuc enabled more sensitive determination than wtGLuc, whereas ALP' showed nearly equivalent performance. Its slowest alteration rate for light intensity after starting the enzyme reaction should enable robust batch-by-batch assay operations. Thus, we concluded that scFv-NLuc fusions serve as suitable probes in various types of immunoassays and may facilitate higher sensitivities with practical specificities.
酶联免疫吸附测定(ELISA)对于监测各种生物标志物至关重要。竞争性和非竞争性(夹心)测定形式分别用于确定半抗原和大分子水平。两种形式都需要更灵敏地检测报告酶以提高测定灵敏度。我们之前报道了野生型高斯荧光素酶(wtGLuc)作为与抗体单链Fv片段(scFv)的融合伙伴用于开发灵敏的发光ELISA的效用。在此,我们从与wtGLuc和碱性磷酸酶突变体(ALP')比较的角度评估了最近开发的荧光素酶纳米荧光素酶(NLuc)作为与scFv融合伙伴的效用。分别选择甲状腺素(T)和T标记的白蛋白作为模型半抗原和大分子抗原。将内部制备的抗T scFv与NLuc、wtGLuc或ALP'融合。scFv-NLuc融合蛋白的检测限[LOD;59 zmol(每次测定)]分别比wtGLuc-和ALP'-融合蛋白低47倍和29倍。在竞争性T ELISA中,NLuc融合蛋白的LOD(0.67 pg)分别比wtGLuc-和ALP'-融合蛋白低9.3倍和6.3倍,在临床应用中具有更高的特异性。使用过氧化物酶标记的二抗的典型比色ELISA的LOD比基于NLuc的ELISA高70倍。NLuc融合蛋白的另一个优点在夹心测定中得到体现;T标记白蛋白的LOD(5.0 fmol)比其他发光ELISA低>6倍。在为计数噬菌体颗粒而开发的另一种夹心测定中,NLuc比wtGLuc能实现更灵敏的测定,而ALP'表现出几乎相当的性能。酶反应开始后其光强度变化率最慢应能实现稳健的逐批测定操作。因此,我们得出结论,scFv-NLuc融合蛋白可作为各种类型免疫测定的合适探针,并可能以实际的特异性促进更高的灵敏度。